Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00958841 · ADVERSE EVENTS

Adverse events

Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin · Source last updated 2016-07-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame
Not reported
Other-event reporting threshold
5%
Participants affected / participants at risk, as reported
Safety groupSerious eventsOther eventsDeaths
Pancreatic NETs (PNETs)

Patients received pasireotide LAR at 60 mg approximately once every 28 days for 6 months during the core treatment period and additional treatment cycles up to a total of 48 months during the extension phase.

10 / 2523 / 25Not reported / Not reported
Pituitary NETs (PiNETs)

Patients received pasireotide LAR at 60 mg approximately once every 28 days for 6 months during the core treatment period and additional treatment cycles up to a total of 48 months during the extension phase.

8 / 7271 / 72Not reported / Not reported
Ectopic ACTH-secrting Tumors (EAS)

Patients received pasireotide LAR at 60 mg approximately once every 28 days for 6 months during the core treatment period and additional treatment cycles up to a total of 48 months during the extension phase.

5 / 77 / 7Not reported / Not reported
Nelsons Syndrome

Nelson's syndrome is based on disease specific primary biochemical tumor markers. Patients received pasireotide LAR at 60 mg approximately once every 28 days for 6 months during the core treatment period and additional treatment cycles up to a total of 48.

9 / 1414 / 14Not reported / Not reported

Group identifiers: EG000: Pancreatic NETs (PNETs) · EG001: Pituitary NETs (PiNETs) · EG002: Ectopic ACTH-secrting Tumors (EAS) · EG003: Nelsons Syndrome

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Anaemia
  2. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Coagulopathy
  3. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Pancytopenia
  4. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Thrombocytopenia
  5. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Bradycardia
  6. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Cardiac failure
  7. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Prinzmetal angina
  8. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Tricuspid valve incompetence
  9. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Congenital, familial and genetic disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Haemophilia A without inhibitors
  10. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Ear and labyrinth disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Tinnitus
  11. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Endocrine disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Adrenal insufficiency
  12. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Endocrine disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Adrenocortical insufficiency acute

Other reported adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      3
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      2
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Anaemia
  2. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      2
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Thrombocytopenia
  3. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      2
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      2
      num At Risk
      14
    term
    Palpitations
  4. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      8
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      3
      num At Risk
      14
    term
    Sinus bradycardia
  5. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      3
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Tachycardia
  6. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Ear and labyrinth disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Ear discomfort
  7. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Ear and labyrinth disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      3
      num At Risk
      14
    term
    Ear pain
  8. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Ear and labyrinth disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Eustachian tube disorder
  9. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Ear and labyrinth disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Tinnitus
  10. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Ear and labyrinth disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      4
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Vertigo
  11. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Endocrine disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Adrenal insufficiency
  12. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Eye disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Blindness
Complete source fields
event Groups
  1. description
    Patients received pasireotide LAR at 60 mg approximately once every 28 days for 6 months during the core treatment period and additional treatment cycles up to a total of 48 months during the extension phase.
    id
    EG000
    other Num Affected
    23
    other Num At Risk
    25
    serious Num Affected
    10
    serious Num At Risk
    25
    title
    Pancreatic NETs (PNETs)
  2. description
    Patients received pasireotide LAR at 60 mg approximately once every 28 days for 6 months during the core treatment period and additional treatment cycles up to a total of 48 months during the extension phase.
    id
    EG001
    other Num Affected
    71
    other Num At Risk
    72
    serious Num Affected
    8
    serious Num At Risk
    72
    title
    Pituitary NETs (PiNETs)
  3. description
    Patients received pasireotide LAR at 60 mg approximately once every 28 days for 6 months during the core treatment period and additional treatment cycles up to a total of 48 months during the extension phase.
    id
    EG002
    other Num Affected
    7
    other Num At Risk
    7
    serious Num Affected
    5
    serious Num At Risk
    7
    title
    Ectopic ACTH-secrting Tumors (EAS)
  4. description
    Nelson's syndrome is based on disease specific primary biochemical tumor markers. Patients received pasireotide LAR at 60 mg approximately once every 28 days for 6 months during the core treatment period and additional treatment cycles up to a total of 48.
    id
    EG003
    other Num Affected
    14
    other Num At Risk
    14
    serious Num Affected
    9
    serious Num At Risk
    14
    title
    Nelsons Syndrome
frequency Threshold
5
other Events
  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      3
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      2
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Anaemia
  2. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      2
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Thrombocytopenia
  3. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      2
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      2
      num At Risk
      14
    term
    Palpitations
  4. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      8
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      3
      num At Risk
      14
    term
    Sinus bradycardia
  5. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      3
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Tachycardia
  6. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Ear and labyrinth disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Ear discomfort
  7. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Ear and labyrinth disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      3
      num At Risk
      14
    term
    Ear pain
  8. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Ear and labyrinth disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Eustachian tube disorder
  9. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Ear and labyrinth disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Tinnitus
  10. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Ear and labyrinth disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      4
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Vertigo
  11. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Endocrine disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Adrenal insufficiency
  12. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Eye disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Blindness
serious Events
  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Anaemia
  2. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Coagulopathy
  3. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Pancytopenia
  4. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Thrombocytopenia
  5. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Bradycardia
  6. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Cardiac failure
  7. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Prinzmetal angina
  8. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Tricuspid valve incompetence
  9. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Congenital, familial and genetic disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Haemophilia A without inhibitors
  10. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Ear and labyrinth disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Tinnitus
  11. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Endocrine disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      14
    term
    Adrenal insufficiency
  12. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Endocrine disorders
    source Vocabulary
    17.0
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      25
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      72
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      7
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      14
    term
    Adrenocortical insufficiency acute

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice